The potential of dopamine receptor D2 (DRD2) as a therapeutic target for tackling pancreatic cancer
Author:
Affiliation:
1. Department of Human Genetics, McGill University, Montreal, QC, Canada
2. McGill University and Genome Quebec Innovation Centre, Montreal, QC, Canada
3. Functional Genome Analysis, Deutsches Krebsforschungszentrum (DKFZ), Heidelberg, Germany
Funder
Canadian Institutes of Health Research
Publisher
Informa UK Limited
Subject
Clinical Biochemistry,Drug Discovery,Pharmacology,Molecular Medicine
Link
https://www.tandfonline.com/doi/pdf/10.1080/14728222.2019.1606904
Reference17 articles.
1. Projecting Cancer Incidence and Deaths to 2030: The Unexpected Burden of Thyroid, Liver, and Pancreas Cancers in the United States
2. Optimizing the outcomes of pancreatic cancer surgery
3. Therapeutic developments in pancreatic cancer: current and future perspectives
4. Increased Survival in Pancreatic Cancer with nab-Paclitaxel plus Gemcitabine
5. FOLFIRINOX or Gemcitabine as Adjuvant Therapy for Pancreatic Cancer
Cited by 14 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Multi-objective latent space optimization of generative molecular design models;Patterns;2024-08
2. Correlation between Neurotransmitters (Dopamine, Epinephrine, Norepinephrine, Serotonin), Prognostic Nutritional Index, Glasgow Prognostic Score, Systemic Inflammatory Response Markers, and TNM Staging in a Cohort of Colorectal Neuroendocrine Tumor Patients;International Journal of Molecular Sciences;2024-06-26
3. Research progress on the roles of dopamine and dopamine receptors in digestive system diseases;Journal of Cellular and Molecular Medicine;2024-03-17
4. Ferroptosis in cancer: from molecular mechanisms to therapeutic strategies;Signal Transduction and Targeted Therapy;2024-03-08
5. The DRD2 Antagonist Haloperidol Mediates Autophagy-Induced Ferroptosis to Increase Temozolomide Sensitivity by Promoting Endoplasmic Reticulum Stress in Glioblastoma;Clinical Cancer Research;2023-05-30
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3